Smart Disposable Medical Device Global Market Report 2025

The smart disposable medical device market size has grown exponentially in recent years. It will grow from $5.39 billion in 2024 to $6.49 billion in 2025 at a compound annual growth rate (CAGR) of 20.3%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, higher healthcare expenditure, increasing adoption of minimally invasive procedures, expansion of digital health solutions, and greater emphasis on patient safety.

The smart disposable medical device market size is expected to see rapid growth in the next few years. It will grow to $13.44 billion in 2029 at a compound annual growth rate (CAGR) of 20%. The growth during the forecast period can be attributed to the increasing demand for remote patient monitoring, rising adoption of connected healthcare devices, growing focus on personalized treatment, expansion of smart drug delivery systems, and the rising occurrence of hospital-acquired infections. Key trends during the forecast period include technological progress in connected devices, innovations in sensor-based monitoring, advancements in smartphone-integrated medical tools, research and development in digital therapeutics, and progress in artificial intelligence integration.

The growing emphasis on reducing hospital-acquired infections is expected to drive the expansion of the smart disposable medical device market in the coming years. Hospital-acquired infections are infections that develop in patients during hospital stays or medical treatment, typically occurring 48 hours or more after admission and not present at the time of entry. The increasing focus on reducing these infections stems from the need to enhance patient safety, as prevention lowers the risk of complications and supports faster recovery. Smart disposable medical devices help minimize hospital-acquired infections by ensuring single-use sterility and offering real-time monitoring, which reduces cross-contamination risks and strengthens patient protection. For instance, in March 2025, the Health Security Agency, a United Kingdom-based government organization, reported that hospital-acquired infections affected 7.6 percent of patients in 2023, with pneumonia and lower respiratory tract infections accounting for 29.6 percent of cases, followed by urinary tract infections at 17.5 percent and sepsis or disseminated infections at 10.6 percent. Therefore, the growing focus on reducing hospital-acquired infections is contributing to the expansion of the smart disposable medical device market.

Leading companies in the smart disposable medical device market are prioritizing innovation and digital health integration through developments such as dual-therapy compatibility, designed to enable seamless monitoring and management of multiple drug types using a single connected platform. Dual-therapy compatibility refers to a smart medical device’s ability to support and track two different therapies or medications simultaneously. For example, in January 2023, Biocorp, a France-based medical technology company, received approval from the US Food and Drug Administration for Mallya, a smart medical device for disposable injector pens. This device allows users of both insulin and GLP-1 receptor agonist pens to connect their devices to a smartphone to track dosage details along with the date and time of each injection. This connectivity feature enhances therapy accuracy, promotes treatment adherence, and improves overall patient outcomes.

In June 2023, Novo Nordisk, a Denmark-based healthcare company, acquired Biocorp for $178 million (154 million euros). This acquisition aims to strengthen Novo Nordisk’s digital health capabilities by integrating Biocorp’s smart connected technologies, such as the Mallya insulin pen sensor, to enhance chronic disease management and improve patient outcomes. Biocorp is a France-based manufacturer specializing in smart disposable medical devices.

Major players in the smart disposable medical device market are Cardinal Health, Abbott Laboratories, Medtronic Plc, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Smith & Nephew Plc, Dexcom Inc., West Pharmaceutical Inc., Insulet Corporation, iRhythm Technologies Inc., Ypsomed Holding AG, Sensirion AG, Eko Health, Senseonics Holdings Inc., Element Science Inc., Biotricity Inc., Tasso Inc., Gentag Inc., and Nemaura Medical Inc.

North America was the largest region in the smart disposable medical device market in 2024. The regions covered in smart disposable medical device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The smart disposable medical device market research report is one of a series of new reports that provides smart disposable medical device market statistics, including smart disposable medical device industry global market size, regional shares, competitors with a smart disposable medical device market share, detailed smart disposable medical device market segments, market trends and opportunities, and any further data you may need to thrive in the smart disposable medical device industry. This smart disposable medical device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A smart disposable medical device is a single-use medical instrument integrated with advanced technologies such as sensors, microprocessors, or wireless communication systems that allow it to collect, monitor, analyze, or transmit physiological or diagnostic data during use. These devices are engineered to maintain high accuracy and reliability throughout their functional lifespan, ensuring precise performance before being safely disposed of to prevent contamination and eliminate the need for sterilization.

The primary product types of smart disposable medical devices include smart syringes, smart inhalers, smart wearable patches, and smart pills. Smart syringes are medical instruments developed to administer injections safely, accurately, and efficiently while minimizing the risks of reuse and incorrect dosing. These devices support various connectivity options such as Bluetooth, near field communication, and wireless fidelity and are utilized for patient monitoring, drug delivery, and diagnostic purposes. They are used across several end-user settings, including hospitals and clinics, home care, and ambulatory surgical centers.

The countries covered in the smart disposable medical device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart disposable medical device market consists of sales of smart catheters, smart bandages, smart biopsy needles, connected surgical staplers, and smart wound dressings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.